Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9709717.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated the rate of radiologic progression, as measured by carpal length, in 26 children with juvenile chronic arthritis who were treated with methotrexate. After 2 years of treatment, the carpal length was significantly more deteriorated in nonresponders in both the "better" wrist (P = .001) and the "worse" wrist (P = .005). These results show that methotrexate may have a "disease modifying" potential in juvenile chronic arthritis.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Juvenile
- Immunosuppressive Agents
- Methotrexate